# AsiDNA Children, Adolescents and Young Adults

> **NCT05394558** · PHASE1,PHASE2 · TERMINATED · sponsor: **Institut Curie** · enrollment: 8 (actual)

## Conditions studied

- Recurrent High-grade Glioma

## Interventions

- **DRUG:** AsiDNA

## Key facts

- **NCT ID:** NCT05394558
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-27
- **Primary completion:** 2023-09-20
- **Final completion:** 2023-09-20
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** IDMC recommendations
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394558, "AsiDNA Children, Adolescents and Young Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05394558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*